☆ 4.7 Editorial Material

Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours

LANCET ONCOLOGY (2022)

Get Full Text
Add to Collection

Journal

LANCET ONCOLOGY
Volume 23, Issue 7, Pages 833-835

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S1470-2045(22)00203-0

Keywords

-

Categories

Oncology

Funding

  1. Novartis
  2. CelldexTherapeutics
  3. Alexander von Humboldt Foundation
  4. Asher-Bio
  5. BMS
  6. BioNTech
  7. MSD

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.